Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1

Author(s):  Giacoia George P, Taylor-Zapata Perdita, Mattison Donald

Issue:  Jan/Feb 2007 - Pediatric Patients
View All Articles in Issue

Page(s):  5-8

Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1 Page 1
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1 Page 2
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1 Page 3
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1 Page 4

Download in electronic PDF format for $75

Abstract:  The development and compounding of pharmacotherapeutic formulations that are suitable for infants and young children can be a challenging problem. This problem results from the lack of knowledge on the acceptability of different dosage forms and formulations in children in relation to age and developmental status, as well as the lack of reliable documentation of formulations used in pediatric clinical trials. As part of its mandate under the Best Pharmaceuticals for Children Act to improve pediatric therapeutics, the National Institute of Child Health and Human Development has sponsored the Pediatric Formulation Initiative. The goal of this ongoing initiative is to address the issues and concerns associated with pediatric therapeutics by convening groups of researchers and experts in pediatric formulations from academia, pharmaceutical companies, the National Institutes of Health, and the U.S. Food and Drug Administration.

Related Keywords: NIH, NICHD, EXTEMPORANEOUS, NATIONAL INSTITUTE FOR CHILD HEALTH AND HUMAN DEVELOPMENT, CHILDREN, INFANTS, USP, UNITED STATES PHARMACOPEIA, OFF-LABEL, FDA, FDAMA, US FOOD AND DRUG ADMINISTRATION, UNITED KINGDOM, NATIONAL HEALTH SERVICE, REGULATORY AGENCY,

Related Categories: EXCIPIENTS, LEGAL, PEDIATRICS, PATIENT COMPLIANCE, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Giacoia George P
, Taylor-Zapata Perdita, Mattison Donald
May/Jun 2007
Pg. 220-225

Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1
Giacoia George P
, Taylor-Zapata Perdita, Mattison Donald
Jan/Feb 2007
Pg. 5-8

Oral Rehydration Salts (World Health Organization/United Nations Children's Fund)
Allen Loyd V Jr
Sep/Oct 2006
Pg. 390

Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children
Pramann Lance A
, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
May/Jun 2016
Pg. 257-261

Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children
Nahata Milap C
May/Jun 2016
Pg. 247-249

Healthful Living: Good Practices for Good Health
Jackson Kathy
May/Jun 2002
Pg. 164-166

Pediatric Compounding: Coloring Outside the Lines
Preckshot John
Jan/Feb 2001
Pg. 6-8

Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets
Kaila Nitin
, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D
May/Jun 2003
Pg. 233-239

Current Trends and Emerging Priorities in Compounded Preparations for Children
Parrish Richard H II
Sep/Oct 2018
Pg. 358-366

Women's Oral Health: Is There a Hormonal Link?
Preckshot John
Jan/Feb 2004
Pg. 10-14

Maillard Reactions in Pharmaceutical Formulations and Human Health
Newton David W
Jan/Feb 2011
Pg. 32-40

Topical Cholesterol/Simvastatin Gel for the Treatment of CHILD Syndrome in an Adolescent
Cho Sung Kyung
, Ashworth Lisa Diggs, Goldman Shauna
Sep/Oct 2020
Pg. 367-369

Child-safety Containers/Devices and Compounding
Allen Loyd V Jr
Sep/Oct 2017
Pg. 364-370

Autism in Children
Cave Stephanie
Jan/Feb 2001
Pg. 18-19

Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada
Prot-Labarthe Sonia
, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
Jul/Aug 2008
Pg. 365-367

Pediatric Health Care: An Introduction
Williams LaVonn A
Jan/Feb 2013
Pg. 6-8

Sevelamer Suspension in Children with End-Stage Renal Disease
McElhiney Linda F
Jan/Feb 2007
Pg. 20-24

Prescription: Pediatric Formulation Initiatives
Allen Loyd V Jr
Nov/Dec 2005
Pg. 410

Extemporaneous Formulations in Pediatric Patients
Nahata Milap C
Jul/Aug 1999
Pg. 274-276

Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage
Kumaravelrajan Rajagopal
, Karthik B, Venkatasan Suba
Nov/Dec 2022
Pg. 516-521

Return to Top